Tekla Capital Management as of June 30, 2012
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 65 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 7.8 | $44M | 866k | 51.28 | |
| Celgene Corporation | 6.1 | $35M | 538k | 64.16 | |
| Alexion Pharmaceuticals | 5.8 | $33M | 330k | 99.30 | |
| Perrigo Company | 4.7 | $27M | 225k | 117.93 | |
| Regeneron Pharmaceuticals (REGN) | 4.5 | $26M | 223k | 114.22 | |
| Biogen Idec (BIIB) | 4.5 | $26M | 177k | 144.38 | |
| Akorn | 3.5 | $20M | 1.2M | 15.77 | |
| Teva Pharmaceutical Industries (TEVA) | 3.1 | $18M | 443k | 39.44 | |
| Mylan | 2.9 | $17M | 781k | 21.37 | |
| Medivation | 2.7 | $15M | 166k | 91.40 | |
| Amarin Corporation (AMRN) | 2.5 | $15M | 1.0M | 14.46 | |
| Merck & Co (MRK) | 2.3 | $13M | 319k | 41.75 | |
| Allergan | 2.2 | $13M | 136k | 92.57 | |
| Hologic (HOLX) | 2.1 | $12M | 653k | 18.04 | |
| Shire | 2.0 | $11M | 130k | 86.39 | |
| Gen-Probe Incorporated | 2.0 | $11M | 136k | 82.20 | |
| Warner Chilcott Plc - | 1.8 | $11M | 586k | 17.92 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $11M | 1.3M | 7.91 | |
| Elan Corporation | 1.8 | $10M | 713k | 14.59 | |
| Alere | 1.7 | $9.9M | 510k | 19.44 | |
| United Therapeutics Corporation (UTHR) | 1.7 | $9.7M | 197k | 49.38 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $8.9M | 160k | 55.92 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $8.7M | 168k | 51.91 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.5 | $8.4M | 65k | 129.95 | |
| Verastem | 1.4 | $8.1M | 885k | 9.18 | |
| Impax Laboratories | 1.3 | $7.5M | 372k | 20.27 | |
| Alkermes (ALKS) | 1.2 | $7.1M | 417k | 16.97 | |
| Nektar Therapeutics (NKTR) | 1.2 | $7.0M | 869k | 8.07 | |
| Watson Pharmaceuticals | 1.2 | $6.8M | 92k | 73.99 | |
| Cubist Pharmaceuticals | 1.2 | $6.8M | 179k | 37.91 | |
| Vivus | 1.2 | $6.8M | 238k | 28.54 | |
| Covance | 1.2 | $6.7M | 140k | 47.85 | |
| Life Technologies | 1.0 | $5.9M | 132k | 44.99 | |
| Baxter International (BAX) | 1.0 | $5.6M | 105k | 53.15 | |
| Intellipharmaceuticsintl Inc C | 1.0 | $5.6M | 1.7M | 3.22 | |
| UnitedHealth (UNH) | 1.0 | $5.5M | 94k | 58.50 | |
| Ariad Pharmaceuticals | 1.0 | $5.5M | 322k | 17.21 | |
| Endo Pharmaceuticals | 1.0 | $5.4M | 176k | 30.98 | |
| IDEXX Laboratories (IDXX) | 0.9 | $5.4M | 56k | 96.13 | |
| McKesson Corporation (MCK) | 0.9 | $5.3M | 57k | 93.75 | |
| Ironwood Pharmaceuticals (IRWD) | 0.9 | $4.9M | 359k | 13.78 | |
| Illumina (ILMN) | 0.8 | $4.7M | 115k | 40.39 | |
| Accuray Incorporated (ARAY) | 0.8 | $4.6M | 672k | 6.84 | |
| CVS Caremark Corporation (CVS) | 0.8 | $4.5M | 95k | 46.73 | |
| NPS Pharmaceuticals | 0.7 | $4.0M | 469k | 8.61 | |
| Aetna | 0.7 | $3.8M | 99k | 38.77 | |
| Bruker Corporation (BRKR) | 0.7 | $3.8M | 285k | 13.31 | |
| Ceres | 0.6 | $3.5M | 428k | 8.15 | |
| Synta Pharmaceuticals | 0.6 | $3.4M | 625k | 5.47 | |
| Dendreon Corporation | 0.5 | $3.1M | 416k | 7.40 | |
| Jazz Pharmaceuticals (JAZZ) | 0.5 | $2.9M | 65k | 45.01 | |
| Curis | 0.5 | $2.8M | 515k | 5.40 | |
| OncoGenex Pharmaceuticals | 0.3 | $1.5M | 113k | 13.44 | |
| Zogenix | 0.3 | $1.6M | 625k | 2.48 | |
| Acorda Therapeutics | 0.3 | $1.5M | 63k | 23.56 | |
| Aegerion Pharmaceuticals | 0.3 | $1.5M | 101k | 14.84 | |
| Keryx Biopharmaceuticals | 0.2 | $1.1M | 586k | 1.80 | |
| Cornerstone Therapeutics | 0.2 | $1.1M | 174k | 6.33 | |
| Palomar Medical Technologies | 0.2 | $957k | 113k | 8.50 | |
| Targacept | 0.1 | $839k | 195k | 4.30 | |
| Addus Homecare Corp (ADUS) | 0.1 | $870k | 177k | 4.91 | |
| Amgen (AMGN) | 0.1 | $731k | 10k | 73.03 | |
| Celldex Therapeutics | 0.1 | $727k | 140k | 5.19 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $146k | 104k | 1.41 | |
| iCAD | 0.0 | $40k | 87k | 0.46 |
